Copyright
©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 427-432
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.427
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.427
Figure 1 Mean serum CA19-9 and CEA concentrations.
aP < 0.001, bP < 0.05 vs benign biliary diseases or healthy individuals. cP < 0.05 vs serum CEA.
Figure 2 Mean postoperative serum CA19-9 and CEA levels of resectable group and mean serum CA19-9 and CEA levels of the unresectable group.
- Citation: Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World J Gastroenterol 2004; 10(3): 427-432
- URL: https://www.wjgnet.com/1007-9327/full/v10/i3/427.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i3.427